Prof. Dr. Werner Albrich
chief of service
Division of Infectious Diseases, Infection Prevention and Travel Medicine · Dept. I
Healthcare‑associated infections in intensive care unit patients with and without COVID-19: a single center prospective surveillance study.
Bloch N, Rüfenacht S, Ludwinek M, Frick W, Kleger G, Schneider F, Albrich W, Flury D, Kuster S, Schlegel M, Kohler P. Healthcare‑associated infections in intensive care unit patients with and without COVID-19: a single center prospective surveillance study. Antimicrob Resist Infect Control 2023; 12:147.
Dec 18, 2023Healthcare‑associated infections in intensive care unit patients with and without COVID-19: a single center prospective surveillance study.
Dec 18, 2023Antimicrob Resist Infect Control 2023; 12:147
Bloch Nando, Rüfenacht Susanne, Ludwinek Magdalena, Frick Waldemar, Kleger Gian-Reto, Schneider Florian, Albrich Werner, Flury Domenica, Kuster Stefan, Schlegel Matthias, Kohler Philipp
The potential clinical value of pairing procalcitonin and lung ultrasonography to guide antibiotic therapy in patients with community-acquired pneumonia: a narrative review.
Bessat C, Boillat-Blanco N, Albrich W. The potential clinical value of pairing procalcitonin and lung ultrasonography to guide antibiotic therapy in patients with community-acquired pneumonia: a narrative review. Expert Rev Respir Med 2023; 17:919-927.
Nov 24, 2023The potential clinical value of pairing procalcitonin and lung ultrasonography to guide antibiotic therapy in patients with community-acquired pneumonia: a narrative review.
Nov 24, 2023Expert Rev Respir Med 2023; 17:919-927
Bessat Cécile, Boillat-Blanco Noémie, Albrich Werner
Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial.
Urwyler P, Leimbacher M, Charitos P, Moser S, Fehrman-Ekholm I, Trendelenburg M, Thoma R, Sumer J, Camacho-Ortiz A, Bacci M, Huber L, Stüssi-Helbling M, Albrich W, Sendi P, Osthoff M. Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial. Front Immunol 2023; 14:1255292.
Oct 27, 2023Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial.
Oct 27, 2023Front Immunol 2023; 14:1255292
Urwyler Pascal, Leimbacher Marina, Charitos Panteleimon, Moser Stephan, Fehrman-Ekholm Ingela, Trendelenburg Marten, Thoma Reto, Sumer Johannes, Camacho-Ortiz Adrián, Bacci Marcelo R, Huber Lars Chistian, Stüssi-Helbling Melina, Albrich Werner, Sendi Parham, Osthoff Michael
Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients.
Lichtensteiger C, Koblischke M, Berner F, Jochum A, Sinnberg T, Balciunaite B, Purde M, Walter V, Abdou M, Hofmeister K, Kohler P, Vernazza P, Albrich W, Kahlert C, Zoufaly A, Traugott M, Kern L, Pietsch U, Kleger G, Filipovic M, Kneilling M, Cozzio A, Pop O, Bomze D, Bergthaler A, Hasan A, Aberle J, Flatz L. Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients. J Autoimmun 2023; 140:103118.
Oct 10, 2023Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients.
Oct 10, 2023J Autoimmun 2023; 140:103118
Lichtensteiger Christa, Koblischke Maximilian, Berner Fiamma, Jochum Ann-Kristin, Sinnberg Tobias, Balciunaite Beatrice, Purde Mette-Triin, Walter Vincent, Abdou Marie-Therese, Hofmeister Kathrin, Kohler Philipp, Vernazza Pietro L, Albrich Werner, Kahlert Christian, Zoufaly Alexander, Traugott Marianna T, Kern Lukas, Pietsch Urs, Kleger Gian-Reto, Filipovic Miodrag, Kneilling Manfred, Cozzio Antonio, Pop Oltin, Bomze David, Bergthaler Andreas, Hasan Ali, Aberle Judith, Flatz Lukas
Validation of sTREM-1 and IL-6 based algorithms for outcome prediction of COVID-19.
Van Singer M, Brahier T, Koch J, Hugli P, Weckman A, Zhong K, Kain T, Leligdowicz A, Bernasconi E, Ceschi A, Parolari S, Vuichard-Gysin D, Kain K, Albrich W, Boillat-Blanco N. Validation of sTREM-1 and IL-6 based algorithms for outcome prediction of COVID-19. BMC Infect Dis 2023; 23:630.
Sep 26, 2023Validation of sTREM-1 and IL-6 based algorithms for outcome prediction of COVID-19.
Sep 26, 2023BMC Infect Dis 2023; 23:630
Van Singer Mathias, Brahier Thomas, Koch Jana, Hugli Pr Olivier, Weckman Andrea M, Zhong Kathleen, Kain Taylor J, Leligdowicz Aleksandra, Bernasconi Enos, Ceschi Alessandro, Parolari Sara, Vuichard-Gysin Danielle, Kain Kevin C, Albrich Werner, Boillat-Blanco Noémie
The Effects of Hospitalisation on the Serum Metabolome in COVID-19 Patients.
Hensen T, Fässler D, O'Mahony L, Albrich W, Barda B, Garzoni C, Kleger G, Pietsch U, Suh N, Hertel J, Thiele I. The Effects of Hospitalisation on the Serum Metabolome in COVID-19 Patients. Metabolites 2023; 13
Aug 16, 2023The Effects of Hospitalisation on the Serum Metabolome in COVID-19 Patients.
Aug 16, 2023Metabolites 2023; 13
Hensen Tim, Fässler Daniel, O'Mahony Liam, Albrich Werner, Barda Beatrice, Garzoni Christian, Kleger Gian-Reto, Pietsch Urs, Suh Noémie, Hertel Johannes, Thiele Ines
STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease.
Woelfel S, Dütschler J, König M, Dulovic A, Graf N, Junker D, Oikonomou V, Krieger-Grübel C, Truniger S, Franke A, Eckhold A, Forsch K, Koller S, Wyss J, Krupka N, Oberholzer M, Frei N, Geissler N, Schaub P, STAR SIGN Study Investigators, Albrich W, Friedrich M, Schneiderhan-Marra N, Misselwitz B, Korte W, Bürgi J, Brand S. STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2023; 58:678-691.
Aug 12, 2023STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease.
Aug 12, 2023Aliment Pharmacol Ther 2023; 58:678-691
Woelfel Simon, Dütschler Joel, König Marius, Dulovic Alex, Graf Nicole, Junker Daniel, Oikonomou Vasileios, Krieger-Grübel Claudia, Truniger Samuel, Franke Annett, Eckhold Annika, Forsch Kristina, Koller Seraina, Wyss Jacqueline, Krupka Niklas, Oberholzer Melanie, Frei Nicola Fabian, Geissler Nora, Schaub Peter, STAR SIGN Study Investigators, Albrich Werner, Friedrich Matthias, Schneiderhan-Marra Nicole, Misselwitz Benjamin, Korte Wolfgang C, Bürgi Justus J, Brand Stephan
Viral-associated Pulmonary Aspergillosis: Have We Finally Overcome the Debate of Colonization versus Infection?
Albrich W, Lamoth F. Viral-associated Pulmonary Aspergillosis: Have We Finally Overcome the Debate of Colonization versus Infection?. Am J Respir Crit Care Med 2023; 208:230-231.
Aug 1, 2023Viral-associated Pulmonary Aspergillosis: Have We Finally Overcome the Debate of Colonization versus Infection?
Aug 1, 2023Am J Respir Crit Care Med 2023; 208:230-231
Albrich Werner, Lamoth Frédéric
Humoral and cellular BNT162b2 mRNA-based booster vaccine-induced immunity in patients with multiple myeloma and persistence of neutralising antibodies: results of a prospective single-centre cohort study.
Silzle T, Kahlert C, Albrich W, Nigg S, Demmer-Steingruber R, Driessen C, Fischer S. Humoral and cellular BNT162b2 mRNA-based booster vaccine-induced immunity in patients with multiple myeloma and persistence of neutralising antibodies: results of a prospective single-centre cohort study. Swiss Med Wkly 2023; 153:40090.
Jun 15, 2023Humoral and cellular BNT162b2 mRNA-based booster vaccine-induced immunity in patients with multiple myeloma and persistence of neutralising antibodies: results of a prospective single-centre cohort study.
Jun 15, 2023Swiss Med Wkly 2023; 153:40090
Silzle Tobias, Kahlert Christian, Albrich Werner, Nigg Susanne, Demmer-Steingruber Ruth, Driessen Christoph, Fischer Stefanie
Novel Echinacea formulations for the treatment of acute respiratory tract infections in adults-A randomized blinded controlled trial.
Sumer J, Keckeis K, Scanferla G, Frischknecht M, Notter J, Steffen A, Kohler P, Schmid P, Roth B, Wissel K, Vernazza P, Klein P, Schoop R, Albrich W. Novel Echinacea formulations for the treatment of acute respiratory tract infections in adults-A randomized blinded controlled trial. Front Med (Lausanne) 2023; 10:948787.
Apr 17, 2023Novel Echinacea formulations for the treatment of acute respiratory tract infections in adults-A randomized blinded controlled trial.
Apr 17, 2023Front Med (Lausanne) 2023; 10:948787
Sumer Johannes, Keckeis Karin, Scanferla Giulia, Frischknecht Manuel, Notter Julia, Steffen Ana, Kohler Philipp, Schmid Patrick, Roth Bianca, Wissel Kerstin, Vernazza Pietro L, Klein Peter, Schoop Roland, Albrich Werner
Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19.
Sinnberg T, Lichtensteiger C, Ali O, Pop O, Risch L, Brugger S, Velic A, Bomze D, Kohler P, Vernazza P, Albrich W, Kahlert C, Abdou M, Wyss N, Hofmeister K, Niessner H, Zinner C, Gilardi M, Tzankov A, Röcken M, Dulovic A, Shambat S, Ruetalo N, Buehler P, Scheier T, Jochum W, Kern L, Henz S, Schneider T, Kuster G, Lampart M, Siegemund M, Bingisser R, Schindler M, Schneiderhan-Marra N, Kalbacher H, McCoy K, Spengler W, Brutsche M, Macek B, Twerenbold R, Penninger J, Matter M, Flatz L, Jochum A. Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19. Am J Respir Crit Care Med 2023; 207:38-49.
Jan 1, 2023Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19.
Jan 1, 2023Am J Respir Crit Care Med 2023; 207:38-49
Sinnberg Tobias, Lichtensteiger Christa, Ali Omar Hasan, Pop Oltin T, Risch Lorenz, Brugger Silvio D, Velic Ana, Bomze David, Kohler Philipp, Vernazza Pietro, Albrich Werner, Kahlert Christian, Abdou Marie-Therese, Wyss Nina, Hofmeister Kathrin, Niessner Heike, Zinner Carl, Gilardi Mara, Tzankov Alexandar, Röcken Martin, Dulovic Alex, Shambat Srikanth Mairpady, Ruetalo Natalia, Buehler Philipp K, Scheier Thomas C, Jochum Wolfram, Kern Lukas, Henz Samuel, Schneider Tino, Kuster Gabriela M, Lampart Maurin, Siegemund Martin, Bingisser Roland, Schindler Michael, Schneiderhan-Marra Nicole, Kalbacher Hubert, McCoy Kathy D, Spengler Werner, Brutsche Martin H, Macek Boris, Twerenbold Raphael, Penninger Josef M, Matter Matthias S, Flatz Lukas, Jochum Ann-Kristin
The quorum sensing com system regulates pneumococcal colonisation and invasive disease in a pseudo-stratified airway tissue model.
Kahlert C, Nigg S, Onder L, Dijkman R, Diener L, Vidal A, Rodriguez R, Vernazza P, Thiel V, Vidal J, Albrich W. The quorum sensing com system regulates pneumococcal colonisation and invasive disease in a pseudo-stratified airway tissue model. Microbiol Res 2022; 268:127297.
Dec 31, 2022The quorum sensing com system regulates pneumococcal colonisation and invasive disease in a pseudo-stratified airway tissue model.
Dec 31, 2022Microbiol Res 2022; 268:127297
Kahlert Christian, Nigg Susanne, Onder Lucas, Dijkman Ronald, Diener Liliane, Vidal Ana G Jop, Rodriguez Regulo, Vernazza Pietro, Thiel Volker, Vidal Jorge E, Albrich Werner
Antibiotic treatment durations for common infectious diseases in Switzerland: comparison between real-life and local and international guideline recommendations.
Schaub C, Barnsteiner S, Schönenberg L, Bloch N, Dräger S, Albrich W, Conen A, Osthoff M. Antibiotic treatment durations for common infectious diseases in Switzerland: comparison between real-life and local and international guideline recommendations. J Glob Antimicrob Resist 2022; 32:11-17.
Dec 23, 2022Antibiotic treatment durations for common infectious diseases in Switzerland: comparison between real-life and local and international guideline recommendations.
Dec 23, 2022J Glob Antimicrob Resist 2022; 32:11-17
Schaub Cédéric, Barnsteiner Stefanie, Schönenberg Ladina, Bloch Nando, Dräger Sarah, Albrich Werner, Conen Anna, Osthoff Michael
Outbreak investigation including molecular characterization of community associated methicillin-resistant Staphylococcus aureus in a primary and secondary school in Eastern Switzerland.
Waldeck F, Seiffert S, Manser S, Zemp D, Walt A, Berger C, Albrich W, Schlegel M, Roloff T, Egli A, Nolte O, Kahlert C. Outbreak investigation including molecular characterization of community associated methicillin-resistant Staphylococcus aureus in a primary and secondary school in Eastern Switzerland. Sci Rep 2022; 12:19826.
Nov 18, 2022Outbreak investigation including molecular characterization of community associated methicillin-resistant Staphylococcus aureus in a primary and secondary school in Eastern Switzerland.
Nov 18, 2022Sci Rep 2022; 12:19826
Waldeck Frederike, Seiffert Salome N, Manser Susanne, Zemp Danuta, Walt Angela, Berger Christoph T, Albrich Werner, Schlegel Matthias, Roloff Tim, Egli Adrian, Nolte Oliver, Kahlert Christian
Higher risk for influenza-associated pulmonary aspergillosis (IAPA) in asthmatic patients: A Swiss multicenter cohort study on IAPA in critically ill influenza patients.
Waldeck F, Boroli F, Zingg S, Walti L, Wendel-Garcia P, Conen A, Pagani J, Boggian K, Schnorf M, Siegemund M, Abed-Maillard S, Michot M, Que Y, Bättig V, Suh N, Kleger G, Albrich W. Higher risk for influenza-associated pulmonary aspergillosis (IAPA) in asthmatic patients: A Swiss multicenter cohort study on IAPA in critically ill influenza patients. Influenza Other Respir Viruses 2022
Nov 16, 2022Higher risk for influenza-associated pulmonary aspergillosis (IAPA) in asthmatic patients: A Swiss multicenter cohort study on IAPA in critically ill influenza patients.
Nov 16, 2022Influenza Other Respir Viruses 2022
Waldeck Frederike, Boroli Filippo, Zingg Sandra, Walti Laura N, Wendel-Garcia Pedro David, Conen Anna, Pagani Jean-Luc, Boggian Katia, Schnorf Madeleine, Siegemund Martin, Abed-Maillard Samia, Michot Marc, Que Yok-Ai, Bättig Veronika, Suh Noémie, Kleger Gian-Reto, Albrich Werner
Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2.
Woelfel S, Dütschler J, König M, Graf N, Oikonomou V, Krieger-Grübel C, Truniger S, Franke A, Eckhold A, Forsch K, Wyss J, Krupka N, Albrich W, Frei N, Geissler N, Schaub P, STAR SIGN Study Investigators, Friedrich M, Misselwitz B, Korte W, Bürgi J, Brand S. Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2. Aliment Pharmacol Ther 2022; 57:103-116.
Oct 28, 2022Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2.
Oct 28, 2022Aliment Pharmacol Ther 2022; 57:103-116
Woelfel Simon, Dütschler Joel, König Marius, Graf Nicole, Oikonomou Vasileios, Krieger-Grübel Claudia, Truniger Samuel, Franke Annett, Eckhold Annika, Forsch Kristina, Wyss Jacqueline, Krupka Niklas, Albrich Werner, Frei Nicola Fabian, Geissler Nora, Schaub Peter, STAR SIGN Study Investigators, Friedrich Matthias, Misselwitz Benjamin, Korte Wolfgang C, Bürgi Justus J, Brand Stephan
Pediatric hospital admissions, case severity, and length of hospital stay during the first 18 months of the COVID-19 pandemic in a tertiary children's hospital in Switzerland.
Bögli J, Güsewell S, Strässle R, Kahlert C, Albrich W. Pediatric hospital admissions, case severity, and length of hospital stay during the first 18 months of the COVID-19 pandemic in a tertiary children's hospital in Switzerland. Infection 2022:1-8.
Sep 5, 2022Pediatric hospital admissions, case severity, and length of hospital stay during the first 18 months of the COVID-19 pandemic in a tertiary children's hospital in Switzerland.
Sep 5, 2022Infection 2022:1-8
Bögli Jasmin, Güsewell Sabine, Strässle Rita, Kahlert Christian, Albrich Werner
Humoral and cellular responses to mRNA-based COVID-19 booster vaccinations in patients with solid neoplasms under active treatment.
Su E, Fischer K, R Demmer-Steingruber, Nigg S, Güsewell S, Albrich W, Rothermundt C, Silzle T, Kahlert C. Humoral and cellular responses to mRNA-based COVID-19 booster vaccinations in patients with solid neoplasms under active treatment. ESMO Open 2022; 7:100587.
Aug 24, 2022Humoral and cellular responses to mRNA-based COVID-19 booster vaccinations in patients with solid neoplasms under active treatment.
Aug 24, 2022ESMO Open 2022; 7:100587
Su E, Fischer Katharina S, R Demmer-Steingruber, Nigg Susanne, Güsewell Sabine, Albrich Werner, Rothermundt Christian, Silzle Tobias, Kahlert Christian
A first update on mapping the human genetic architecture of COVID-19.
COVID-19 Host Genetics Initiative, Albrich W. A first update on mapping the human genetic architecture of COVID-19. Nature 2022; 608:E1-E10.
Aug 3, 2022A first update on mapping the human genetic architecture of COVID-19.
Aug 3, 2022Nature 2022; 608:E1-E10
COVID-19 Host Genetics Initiative, Albrich Werner
Comparison of temporal evolution of computed tomography imaging features in COVID-19 and influenza infections in a multicenter cohort study.
Fischer T, El Baz Y, Scanferla G, Graf N, Waldeck F, Kleger G, Frauenfelder T, Bremerich J, Kobbe S, Pagani J, Schindera S, Conen A, Wildermuth S, Leschka S, Strahm C, Wälti S, Dietrich T, Albrich W. Comparison of temporal evolution of computed tomography imaging features in COVID-19 and influenza infections in a multicenter cohort study. Eur J Radiol Open 2022; 9:100431.
Jun 24, 2022Comparison of temporal evolution of computed tomography imaging features in COVID-19 and influenza infections in a multicenter cohort study.
Jun 24, 2022Eur J Radiol Open 2022; 9:100431
Fischer Tim, El Baz Yassir, Scanferla Giulia, Graf Nicole, Waldeck Frederike, Kleger Gian-Reto, Frauenfelder Thomas, Bremerich Jens, Kobbe Sabine Schmidt, Pagani Jean-Luc, Schindera Sebastian, Conen Anna, Wildermuth Simon, Leschka Sebastian, Strahm Carol, Wälti Stephan, Dietrich Tobias, Albrich Werner